Closing in on Stem Cell Treatment for MS

Home

The United States, Japan, Germany and Australia are not the only countries that are working hard to develop stem cell treatments for multiple sclerosis. Recently, a branch of the Edinburgh University, called Stem Cell Sciences, announced that it had signed contract with the Myelin Repair Foundation, based in the United States, which may help to increase efforts to discover treatments for multiple sclerosis. Because early-stage drug tests have typically been done using animal cells, this move is important, as it focuses on human tissues. Stem Cell Sciences, along with the Human Neural Assay Center in Cleveland, Ohio will use human neural stem cells to provide a more dependable source of brain cells.
Prior to now, the need for human brain tissues that can be used in this type of research has been limited, and it also been difficult to maintain in culture environments. It is hoped that human neural stem cells may prove more reliable for the testing processes.

The goal of the focus of studies will be to create a technology through which stem cells may be implanted directly into a body to repair damage caused by not only multiple sclerosis, but AIDS, diabetes, Alzheimer's and Parkinson's. Such treatments also hope to be able to help patients who suffer from spinal cord injuries, as well as strokes. Ongoing research in other countries for the cure to such brain and neural disabilities and conditions is of primary importance to stem research, as well as non-embryonic stem research around the world.

< Prev		Next >

Through this website you are able to link to other websites which are not under the control of Smart Cells International. We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.

Select country: